Vitiligo trials in Japan

2 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo

  Where

  Kofu, Nagoya, Niigata, Shinjuku Ku, Urayasu

  Age

  18 years to 99 years

  People

  210 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07431177 · EU 2025-522301-37-00
• No phaseTaking people
  A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa

  Where

  Ebina-shi, Mitaka-shi, Osaka, Ōta-ku

  Age

  12 years and over

  People

  2,795 worldwide

  Run by

  AbbVie

  See details and how to joinNCT07136467